New drug aims to reduce deaths from severe lung failure
Disease control
Recruiting now
This study tests whether adding a protein called recombinant human plasma gelsolin to standard care can help people with moderate-to-severe acute respiratory distress syndrome (ARDS) caused by pneumonia or other infections. About 600 hospitalized adults will receive either the st…
Phase: PHASE2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control
Last updated Apr 29, 2026 04:58 UTC